Program Integrity Portal FWA Reporting Module - Part C Plans (CMS-10724)

ICR 202002-0938-010

OMB: 0938-1383

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2020-02-20
IC Document Collections
IC ID
Document
Title
Status
240010
New
240008
New
ICR Details
0938-1383 202002-0938-010
Historical Inactive
HHS/CMS CPI
Program Integrity Portal FWA Reporting Module - Part C Plans (CMS-10724)
New collection (Request for a new OMB Control Number)   No
Regular
Comment filed on proposed rule 09/11/2020
Retrieve Notice of Action (NOA) 02/20/2020
Prior to publication of the final rule, the agency should provide to OMB a summary of all comments received on the proposed information collection and identify any changes made in response to these comments.
  Inventory as of this Action Requested Previously Approved
36 Months From Approved
0 0 0
0 0 0
0 0 0

Plan sponsors are required have procedures to voluntarily self-report potential fraud or misconduct related to the MA and Part D programs, respectively, to CMS or its designee. Section 6063 of the SUPPORT Act requires the Secretary of HHS to establish a secure web-based program integrity portal (or other successor technology) that would allow secure communication among the Secretary, MA and Part D plan sponsors, as well as eligible entities with a contract under section 1893, such as Medicare program integrity contractors. The purpose is to enable, through the portal: the referral by such plans of substantiated or suspicious activities (as defined by the Secretary) of a provider of services (including a prescriber) or supplier related to fraud, waste, and abuse for the purpose of initiating or assisting investigations conducted by the eligible entity; and data sharing among such MA plans, prescription drug plans, and the Secretary. CMS plans to utilize a module within the Health Plan Management System (HPMS) as the program integrity portal for information collection and dissemination. Such data and the regular submission and dissemination of this important information would, in our view, strengthen CMS’ ability to oversee plan sponsors’ efforts to maintain an effective fraud, waste, and abuse program. Section 6063 also requires MA plans and Medicare prescription drug plans to report any information related to the inappropriate prescribing of opioids and concerning investigations, credible evidence of suspicious activities of a provider of services (including a prescriber) or supplier, and other actions taken by the plan.

PL: Pub.L. 115 - 271 6063(a)(i)(1) Name of Law: SUPPORT Act
   PL: Pub.L. 115 - 271 6063(b) Name of Law: SUPPORT Act
  
PL: Pub.L. 115 - 271 6063(a)(i)(1) Name of Law: SUPPORT Act
PL: Pub.L. 115 - 271 6063(b) Name of Law: SUPPORT Act

0938-AT97 Proposed rulemaking 85 FR 9002 02/18/2020

  85 FR 9002 02/18/2020
No

2
IC Title Form No. Form Name
Initial Year
Subsequent Years

No
No
Not applicable. This is a new collection of information request.

$1,000,000
No
    No
    No
No
No
No
No
Mitch Bryman 410 786-5258 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/20/2020


© 2024 OMB.report | Privacy Policy